Lumos Diagnostics Holdings Ltd has released a press release.
Lumos Receives US FDA Clearance for FebriDx
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos signs three new agreements with Hologic
- Lumos Diagnostics FY23 First Half Year Results
- Lumos Secures Two Service Agreements With Hologic
- LDX signs agreement to raise $8m & announces General Meeting
- Publication of Data from DISRUPT Clinical Trial in JAMA
Later from Lumos Diagnostics
- Lumos completes $4.75m Placement and launches SPP
- Henry Schein Expands Distribution Partnership For FebriDx
- Lumos Secures Feasibility Project with BDI
- Capital Raise Result and Issue of Early Redemption Notices
- Lumos Receives Research & Development Tax Rebate
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics